Eight years after surgeons removed a parasitic cyst from her liver, a 28-year-old woman arrived at a tuberculosis clinic in Chengdu with seven months of worsening back pain and two months of coughing. Scans showed her T12 to L2 vertebrae being eaten away, abscesses pooling alongside her spine and in her right psoas muscle, and small nodules scattered through both lungs.
Everything pointed to tuberculosis. She had finished treatment for pulmonary TB three years earlier. A family member in her household had active TB. She lived in a region where the disease is common. Her doctors started standard anti-TB therapy. Over the next 12 months, she got worse, and the reason is a case study in how a correct-looking diagnosis can hold for a year while the actual infection keeps spreading.
Twelve Months of the Wrong Drugs
The case, published in August in Tropical Medicine and Health by a team at the Public Health Clinical Center of Chengdu, describes a patient from a nomadic Tibetan family. Because her spine was unstable and paralysis was a live risk, surgeons operated early, removing the T12 to L1 lesion, draining the psoas abscess, and then fusing and fixing the spine.
Tissue from that operation showed granulomatous inflammation with caseous necrosis. That pattern is the signature of tuberculosis, and it pushed the diagnosis further along. But the acid-fast stain came back negative, and no parasitic structures were seen either. The authors are blunt that the absence of definitive pathological evidence for TB was not adequately appreciated at the time.
Twelve months of therapy later, follow-up imaging showed the vertebral destruction worsening, the paravertebral swelling more extensive, a new abscess in the opposite psoas muscle, and both the number and size of the lung nodules increasing.
The Test That Finally Named It
A second operation became necessary to fix failed hardware and drain the new abscess. This time, with the treatment failure and the negative stains in front of them, the team took a different approach and sent surgical pus for metagenomic next-generation sequencing, a hypothesis-free method that reads whatever genetic material is present rather than testing for one suspected organism.
It returned Echinococcus multilocularis, the tapeworm larva that causes alveolar echinococcosis. Anti-TB therapy was stopped, and albendazole started at 20 milligrams per kilogram per day, given in two divided doses and capped at 1 gram daily, in 30-day courses separated by 14-day breaks. Imaging three months after discharge showed marked improvement. By six months, her back pain and numbness had largely resolved.
The authors name the failure directly: anchoring bias, the well-documented tendency to interpret every subsequent finding through the lens of an initial impression. They also list what was skipped. Interferon-gamma release assays and tuberculin skin testing were never done. Serology for echinococcosis was never ordered. The pulmonary nodules were never biopsied. Nor was the sequencing result confirmed by a second method such as targeted PCR.
Their own literature review makes clear this is not a freak occurrence. A similar case in Sichuan was diagnosed by sequencing after suspected spinal tuberculosis, and another Chinese patient with disseminated disease had already started anti-TB drugs before sequencing of cyst fluid identified the parasite.
Why a Liver Parasite Behaves Like a Cancer
Alveolar echinococcosis is not the more familiar hydatid disease. Its close relative Echinococcus granulosus forms discrete cysts. E. multilocularis does something else. The larval mass grows by budding outward into surrounding tissue, infiltrating rather than expanding, which is why clinicians and researchers reach for tumor language to describe it.
The liver is the primary site in nearly all cases, but the parasite spreads to the lungs, brain, and spine. A systematic review in The Lancet Infectious Diseases gathered the vertebral cases specifically, and the Chengdu team notes that extrahepatic disease is present in up to 34 percent of patients at diagnosis and generally signals advanced disease and a poorer outlook.
Global incidence runs between 0.03 and 1.2 cases per 100,000 people per year, with the heaviest burden in Central Asia and western China, according to a review in Clinical Microbiology Reviews. A separate review of European incidence and trends tracked the parasite's circulation across that continent. Foxes and other canids carry the adult worm, and people are infected by swallowing eggs shed in their feces.
Eight Years of Silence Is Not Unusual
The detail that gives this case its weight is the gap. Her liver surgery came eight years before the spinal symptoms began, and she had received antiparasitic treatment afterward. The authors argue this challenges the idea that surgical resection equals cure, noting that dormant viable tissue can persist for long periods before reactivating, and that intervals exceeding 20 years have been documented.
There are real limits here. This is one patient. The original liver pathology report could not be obtained, so the earlier diagnosis rests on her account and on the later sequencing result. The lung nodules were never confirmed by biopsy.
For readers in the United States, alveolar echinococcosis is genuinely rare, and this is not a reason to worry about back pain. The transferable lesson is narrower and applies to any patient anywhere. When a treatment that should work is not working, the diagnosis deserves to be reopened rather than defended. Anyone whose symptoms are progressing despite months of therapy should say so plainly to their clinician.
Key Questions Answered
What is alveolar echinococcosis?
A parasitic disease caused by the larval stage of the tapeworm Echinococcus multilocularis. It usually starts in the liver and grows by infiltrating surrounding tissue rather than forming a discrete cyst.
Why was it mistaken for tuberculosis?
The imaging looked identical, the tissue showed granulomatous inflammation with caseous necrosis, and the patient had a prior TB history plus household exposure in a high-burden region.
What finally made the diagnosis?
Metagenomic next-generation sequencing of pus from a second operation, which identified the parasite's genetic material directly.
How common is this disease?
Rare. Global incidence is estimated at 0.03 to 1.2 cases per 100,000 people annually, concentrated in Central Asia and western China, with additional circulation in parts of Europe.
How do people catch it?
By ingesting parasite eggs shed in the feces of foxes and other canids, typically through contaminated food, water, hands, or soil.
What is the takeaway for ordinary patients?
If a condition is not responding to treatment over months, that lack of response is itself diagnostic information. Patients should report it rather than assuming the treatment simply needs more time.
